Qi WX - Search Results

1

The predictive role of ADC values in prostate cancer patients treated with carbon-ion radiotherapy: initial clinical experience at Shanghai Proton and Heavy Ion Center (SPHIC).

Qi WX, Zhang Q, Li P, Zhang XM, Zhang GY, Wu B, Lu JJ, Jiang GL, Fu S. Qi WX, et al. J Cancer Res Clin Oncol. 2016 Jun;142(6):1361-7. doi: 10.1007/s00432-016-2142-3. Epub 2016 Mar 23. J Cancer Res Clin Oncol. 2016. PMID: 27008005

2

Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials.

Qi WX, Shen Z, Yao Y. Qi WX, et al. J Cancer Res Clin Oncol. 2011 Dec;137(12):1785-90. doi: 10.1007/s00432-011-1052-7. Epub 2011 Sep 14. J Cancer Res Clin Oncol. 2011. PMID: 21915752

3

Bevacizumab increases the risk of severe congestive heart failure in cancer patients: an up-to-date meta-analysis with a focus on different subgroups.

Qi WX, Fu S, Zhang Q, Guo XM. Qi WX, et al. Clin Drug Investig. 2014 Oct;34(10):681-90. doi: 10.1007/s40261-014-0222-1. Clin Drug Investig. 2014. PMID: 25096848 Review.

4

Anti-epidermal-growth-factor-receptor agents and complete responses in the treatment of advanced non-small-cell lung cancer: a meta-analysis of 17 phase III randomized controlled trials.

Qi WX, Fu S, Zhang Q, Guo XM. Qi WX, et al. Curr Med Res Opin. 2015 Jan;31(1):25-33. doi: 10.1185/03007995.2014.978448. Epub 2014 Oct 30. Curr Med Res Opin. 2015. PMID: 25329826 Review.

5

Efficacy and toxicity of anti-VEGF agents in patients with castration-resistant prostate cancer: a meta-analysis of prospective clinical studies.

Qi WX, Fu S, Zhang Q, Guo XM. Qi WX, et al. Asian Pac J Cancer Prev. 2014;15(19):8177-82. doi: 10.7314/apjcp.2014.15.19.8177. Asian Pac J Cancer Prev. 2014. PMID: 25339002 Free article.

6

Incidence and risk of severe infections associated with anti-epidermal growth factor receptor monoclonal antibodies in cancer patients: a systematic review and meta-analysis.

Qi WX, Fu S, Zhang Q, Guo XM. Qi WX, et al. BMC Med. 2014 Nov 5;12:203. doi: 10.1186/s12916-014-0203-5. BMC Med. 2014. PMID: 25369798 Free PMC article.

7

Efficacy and toxicity of molecular targeted therapies in combination with docetaxel for metastatic castration-resistant prostate cancer: a meta-analysis of phase III randomized controlled trials.

Qi WX, Fu S, Zhang Q, Guo XM. Qi WX, et al. J Chemother. 2015 Jun;27(3):181-7. doi: 10.1179/1973947814Y.0000000230. Epub 2014 Dec 10. J Chemother. 2015. PMID: 25492160

8

Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Qi WX, Fu S, Zhang Q, Guo XM. Qi WX, et al. Radiother Oncol. 2015 Mar;114(3):289-95. doi: 10.1016/j.radonc.2014.11.033. Epub 2014 Dec 9. Radiother Oncol. 2015. PMID: 25497556 Review.

9

Bevacizumab increases the risk of infections in cancer patients: A systematic review and pooled analysis of 41 randomized controlled trials.

Qi WX, Fu S, Zhang Q, Guo XM. Qi WX, et al. Crit Rev Oncol Hematol. 2015 Jun;94(3):323-36. doi: 10.1016/j.critrevonc.2015.02.007. Epub 2015 Feb 19. Crit Rev Oncol Hematol. 2015. PMID: 25749417 Review.

10

Incidence and risk of hypertension associated with ramucirumab in cancer patients: A systematic review and meta-analysis.

Qi WX, Fu S, Zhang Q, Guo XM. Qi WX, et al. J Cancer Res Ther. 2016 Apr-Jun;12(2):775-81. doi: 10.4103/0973-1482.148700. J Cancer Res Ther. 2016. PMID: 27461650 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters